Amgen Inc. (AMGN)
NASDAQ · Healthcare
Amgen Inc. Revenue 2007–2025
Amgen Inc. annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Amgen Inc. revenue for the quarter ending March 31, 2026 was 8.6 B, a 5.76% increase year-over-year.
- Amgen Inc. revenue for the twelve months ending March 31, 2026 was 35.5 B, a 13.64% increase year-over-year.
- Amgen Inc. annual revenue for 2025 was 36.8 B, a 9.95% increase from 2024.
- Amgen Inc. annual revenue for 2024 was 33.4 B, a 18.57% increase from 2023.
- Amgen Inc. annual revenue for 2023 was 28.2 B, a 7.09% increase from 2022.
- Amgen Inc. annual revenue for 2022 was 26.3 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Amgen Inc. Market Cap — FAQ
Amgen Inc. (AMGN) market cap over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMGN's market cap history?
The chart and table above show Amgen Inc.'s market cap by year and by quarter, including the growth rate.